[Insulin-sensitizing agents].
Kadowaki
T
T
Department of Metabolic Diseases, Graduate School of Medicine, University of Tokyo.
D000818:Animals; D003920:Diabetes Mellitus / Q000188:drug therapy*; D003921:Diabetes Mellitus, Experimental / Q000188:drug therapy; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007555:Isoxazoles / Q000627:therapeutic use*; D000077205:Pioglitazone; D000077154:Rosiglitazone; D013844:Thiazoles / Q000627:therapeutic use*; D045162:Thiazolidinediones
D007004:Hypoglycemic Agents; D007555:Isoxazoles; D013844:Thiazoles; D045162:Thiazolidinediones; D000077154:Rosiglitazone; C112329:JTT 501; C115174:netoglitazone; D000077205:Pioglitazone